Literature DB >> 16728938

The NCI Developmental Therapeutics Program.

Jerry M Collins1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16728938

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  Early Access to Investigational Agents through the National Cancer Institute's Treatment Referral Center.

Authors:  Tali M Johnson; Matthew J Boron
Journal:  J Hematol Oncol Pharm       Date:  2012-12

2.  Cellular uptake and anticancer activity of carboxylated gallium corroles.

Authors:  Melanie Pribisko; Joshua Palmer; Robert H Grubbs; Harry B Gray; John Termini; Punnajit Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

3.  Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion.

Authors:  Jason D Whitt; Adam B Keeton; Bernard D Gary; Larry A Sklar; Kamlesh Sodani; Zhe-Sheng Chen; Gary A Piazza
Journal:  J Biomed Res       Date:  2015-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.